Inflammation, Glutamate, and Glia in Depression: A Literature Review

No abstract is available for this paper.

• Publication year

  2008

• Venue

  CNS Spectrums

• Publication date

  2008-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1017/S1092852900016734PMID 18567974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tryptophan depletion, serotonin, and depression: where do we stand?

  2025cited by this paper
• Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.

  2008cited by this paper
• Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being.

  2008cited by this paper
• Inflammatory markers in late-life depression: results from a population-based study.

  2008cited by this paper
• From inflammation to sickness and depression: when the immune system subjugates the brain

  2008cited by this paper
• Gene-specific control of inflammation by TLR-induced chromatin modifications

  2008cited by this paper
• Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease

  2007cited by this paper
• Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.

  2007cited by this paper
• Depression and ischemic heart disease: what have we learned from clinical trials?

  2007cited by this paper
• Caspase 1 deficiency reduces inflammation-induced brain transcription

  2007cited by this paper
• Gene-specific control of inflammation by TLR-induced chromatin modifications

  2007cited by this paper
• Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

  2007cited by this paper
• Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

  2007cited by this paper
• Overexpression of IL-1beta by adenoviral-mediated gene transfer in the rat brain causes a prolonged hepatic chemokine response, axonal injury and the suppression of spontaneous behaviour.

  2007cited by this paper
• Inflammation in Human Brain Injury: Intracerebral Concentrations of IL-1α, IL-1β, and Their Endogenous Inhibitor IL-1ra

  2007cited by this paper
• Interferon-&agr; reduces the density of monoaminergic axons in the rat brain

  2007cited by this paper
• The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

  2007cited by this paper
• Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide.

  2007cited by this paper
• Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage

  2007cited by this paper
• Cancer-related fatigue: links with inflammation in cancer patients and survivors.

  2007cited by this paper
• Neurotransmitter receptors on microglia.

  2007cited by this paper
• The NMDA receptor as a therapeutic target in major depressive disorder.

  2007cited by this paper
• New insights into BDNF function in depression and anxiety

  2007cited by this paper
• Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor.

  2007cited by this paper
• Microglia: active sensor and versatile effector cells in the normal and pathologic brain

  2007cited by this paper
• The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro.

  2007cited by this paper
• Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy

  2007cited by this paper
• Negative emotions and 3-year progression of subclinical atherosclerosis.

  2007cited by this paper
• Depressive disorders and immunity: 20 years of progress and discovery.

  2007cited by this paper
• Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms.

  2007cited by this paper
• Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.

  2007cited by this paper
• Reduction in Occipital Cortex γ-Aminobutyric Acid Concentrations in Medication-Free Recovered Unipolar Depressed and Bipolar Subjects

  2007cited by this paper
• Gliogenesis and glial pathology in depression.

  2007cited by this paper
• Medical co-morbidity in depressive disorders.

  2007cited by this paper
• Kynurenine pathway in major depression: evidence of impaired neuroprotection.

  2007cited by this paper
• Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age.

  2007cited by this paper
• Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide

  2007cited by this paper
• Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

  2006cited by this paper
• Neuropsychological impairment and decreased regional cerebral blood flow by interferon treatment in patients with chronic hepatitis: a preliminary study

  2006cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Cytokines sing the blues: inflammation and the pathogenesis of depression.

  2006cited by this paper
• Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.

  2006cited by this paper
• Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.

  2006cited by this paper
• A neurotrophic model for stress-related mood disorders.

  2006cited by this paper
• Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat.

  2006cited by this paper
• Autocrine activation of cultured macrophages by brain-derived neurotrophic factor.

  2006cited by this paper
• TNFα Signaling in Depression and Anxiety: Behavioral Consequences of Individual Receptor Targeting

  2006cited by this paper
• Neuroprotective actions of endogenous interleukin‐1 receptor antagonist (IL‐1ra) are mediated by glia

  2006cited by this paper
• Interferon-Induced Depression in Chronic Hepatitis C: A Review of Its Prevalence, Risk Factors, Biology, and Treatment Approaches

  2006cited by this paper
• The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

  2006cited by this paper
• Post‐MI Psychiatric Syndromes: Six Unanswered Questions

  2006cited by this paper
• Acute inflammation and negative mood: mediation by cytokine activation.

  2005cited by this paper
• Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Th1, Th2, and Th3 cytokine alterations in major depression.

  2005cited by this paper
• Psychiatric epidemiology: it's not just about counting anymore.

  2005cited by this paper
• Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms.

  2005cited by this paper
• Stress and the brain: from adaptation to disease

  2005cited by this paper
• Biological variations, genetic polymorphisms and familial resemblance of TNF-α and IL-6 concentrations: STANISLAS cohort

  2005cited by this paper
• Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide.

  2005cited by this paper
• Glucocorticoids, depression, and mood disorders: structural remodeling in the brain.

  2005cited by this paper
• Age-Dependent Reductions in the Level of Glial Fibrillary Acidic Protein in the Prefrontal Cortex in Major Depression

  2004cited by this paper
• An open-label trial of riluzole in patients with treatment-resistant major depression.

  2004cited by this paper
• Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.

  2004cited by this paper
• Riluzole Enhances Glutamate Uptake in Rat Astrocyte Cultures

  2004cited by this paper
• Alterations of neuroplasticity in depression: the hippocampus and beyond.

  2004cited by this paper
• Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia.

  2004cited by this paper
• Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder

  2003cited by this paper
• Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.

  2003cited by this paper
• Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression.

  2003cited by this paper
• Raised Plasma Levels of Tumor Necrosis Factor &agr; in Patients With Depression: Normalization During Electroconvulsive Therapy

  2003cited by this paper
• Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study.

  2003cited by this paper
• Effects of antidepressants on the production of cytokines.

  2002cited by this paper
• Excess mortality in depression: a meta-analysis of community studies.

  2002cited by this paper
• Control of synapse number by glia.

  2001cited by this paper
• Glutamate uptake.

  2001cited by this paper
• Cytokine-associated emotional and cognitive disturbances in humans.

  2001cited by this paper
• The relationship of depression and stressors to immunological assays: a meta-analytic review.

  2001cited by this paper
• Minocycline Provides Neuroprotection Against N-Methyl-d-aspartate Neurotoxicity by Inhibiting Microglia1

  2001cited by this paper
• Glia‐derived signals induce synapse formation in neurones of the rat central nervous system

  2001cited by this paper
• The immune system, depression and the action of antidepressants.

  2001cited by this paper
• Prefrontal cortical hypometabolism during low-dose interferon alpha treatment

  2000cited by this paper
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper
• Alpha-1-Antichymotrypsin Polymorphism in Schizophrenia: Frequency, Age at Onset and Cognitive Function

  1999cited by this paper
• Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin.

  1999cited by this paper
• Cerebrospinal Cytokine Levels in Patients with Acute Depression

  1999cited by this paper
• The effects of interferon-alpha on the production and action of other cytokines.

  1998cited by this paper
• Expression of the TrkB neurotrophin receptor by thymic macrophages

  1998cited by this paper
• The effects of interferon-alpha on the production and action of other cytokines.

  1998cited by this paper
• Glial Contribution to Glutamate Uptake at Schaffer Collateral–Commissural Synapses in the Hippocampus

  1998cited by this paper
• Major depression and all-cause mortality among white adults in the United States.

  1997cited by this paper
• Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1.

  1997cited by this paper
• Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.

  1997cited by this paper
• Release and uptake of glutamate as related to excitotoxicity.

  1996cited by this paper
• Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

  1996cited by this paper
• Interleukin-1 beta differentially affects interleukin-6 and soluble interleukin-6 receptor in the blood and central nervous system of the monkey.

  1996cited by this paper
• Distribution of neurotrophin receptors in human palatine tonsils: an immunohistochemical study.

  1995cited by this paper
• A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.

  1993cited by this paper
• An evaluation of the role of extracellular amino acids in the delayed neurodegeneration induced by quinolinic acid in the rat striatum.

  1993cited by this paper
• Detection of circulating tumor necrosis factor after endotoxin administration.

  1988cited by this paper

• Astrocytic PCBP1 Suppresses Ferroptosis to Restore Glutamatergic Homeostasis and Mitigate Stress‐Induced Depression in Male Mice

  2025cites this paper
• Protective Effects of N-Acetylcysteine in Alleviating Cocaine-Mediated Microglial Activation and Neuroinflammation

  2025cites this paper
• Beyond the Surface: Tracing the Evolution of Inflammatory Mechanism in Depression through Bibliometric Analysis

  2025cites this paper
• Mechanism of microglia-mediated neuroinflammation, associated cognitive dysfunction, and therapeutic updates in Alzheimer's disease

  2025cites this paper
• Dapagliflozin Reverses LPS‐Induced Depressive–Like Behavior in Mice via Modulation of Glutamate and NF‐κB

  2025cites this paper
• Progress in the Study of Canine Uridine Metabolic Pathway and Post-Stroke Depression

  2025cites this paper
• Alamandine enhanced spatial memory in rats by reducing neuroinflammation and altering BDNF levels in the hippocampus and prefrontal cortex

  2025cites this paper
• Transcutaneous Auricular Vagus Stimulation Attenuates LPS-Induced Depression-Like Behavior by Regulating Central α7nAChR/JAK2 Signaling

  2024cites this paper
• The neuroimmune mechanism of pain induced depression in psoriatic arthritis and future directions.

  2024cites this paper
• Effects on peripheral and central nervous system of key inflammatory intercellular signalling peptides and proteins in psoriasis

  2024cites this paper
• AMPA receptor potentiation alleviates NLRP3 knockout-induced fear generalization in mice.

  2024cites this paper
• Converged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics

  2024cites this paper
• Association of sugary drinks, carbonated beverages, vegetable and fruit juices, sweetened and black coffee, and green tea with subsequent depression: A five-year cohort study.

  2024cites this paper
• Genes associated with depression and coronary artery disease are enriched for cardiomyopathy and inflammatory phenotypes

  2024cites this paper
• Infusions of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produce antidepressant-like effects on learned helplessness rats through BDNF-TrkB signaling and AMPA receptor activation, and strengthen learning ability.

  2023cites this paper
• From the immune system to mood disorders especially induced by Toxoplasma gondii: CD4+ T cell as a bridge

  2023cites this paper
• Association between dietary caffeine, coffee, and tea consumption and depressive symptoms in adults: A systematic review and dose-response meta-analysis of observational studies

  2023cites this paper
• Sclareol exerts an anti-inflammatory effect, possibly through COXs inhibition pathway: In vivo and in silico studies

  2023cites this paper
• Involvement of P2Y1, P2Y6, A1 and A2A Receptors in the Purinergic Inhibition of NMDA-Evoked Noradrenaline Release in the Rat Brain Cortex

  2023cites this paper
• Elevated C-Reactive Protein Levels Modify the Effect of Magnesium on Depressive Symptoms: A Population-Based Study

  2023cites this paper
• A computational account of joint SSRI and anti-inflammatory treatment

  2023cites this paper
• Neuroinflammation in the Evolution of Motor Function in Stroke and Trauma Patients: Treatment and Potential Biomarkers

  2023cites this paper
• Discrimination exposure impacts unhealthy processing of food cues: crosstalk between the brain and gut

  2023cites this paper
• Pathophysiology of Depression: Stingless Bee Honey Promising as an Antidepressant

  2022cites this paper
• Carnosic Acid Mitigates Depression-Like Behavior in Ovariectomized Mice via Activation of Nrf2/HO-1 Pathway

  2022cites this paper
• Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions

  2022cites this paper
• The pathophysiology of major depressive disorder through the lens of systems biology: Network analysis of the psycho-immune-neuroendocrine physiome.

  2022cites this paper
• Multimodal Benefits of Exercise in Patients With Multiple Sclerosis and COVID-19

  2022cites this paper
• Assessing the Evidence for Causal Associations Between Body Mass Index, C-Reactive Protein, Depression, and Reported Trauma Using Mendelian Randomization

  2022cites this paper
• Exploring the role of biologics in depression.

  2022cites this paper
• Ketamine and Other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials

  2022cites this paper
• A 4-week, randomized, double-masked study to evaluate efficacy of deproteinized calf blood extract eye drops versus sodium hyaluronate 0.3% eye drops in dry eye patients with ocular pain.

  2021cites this paper
• Neuro-dermatological association between psoriasis and depression: an immune-mediated inflammatory process validating skin-brain axis theory

  2021influential citation
• Depression and Anxiety

  2021cites this paper
• Major Depression: One Brain, One Disease, One Set of Intertwined Processes

  2021cites this paper
• Medicinal Plants in the Treatment of Depression: Evidence from Preclinical Studies

  2021cites this paper
• Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression.

  2021cites this paper
• Toxoplasma gondii, Suicidal Behavior, and Intermediate Phenotypes for Suicidal Behavior

  2021cites this paper
• Roles of Tumor Necrosis Factor-α and Tumor Necrosis Factor-α Receptor 2 in Inflammation-Related Diseases

  2021cites this paper
• An in vivo evaluation of anti-inflammatory, analgesic and anti-pyretic activities of newly synthesized 1, 2, 4 Triazole derivatives

  2021cites this paper
• Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count

  2021cites this paper
• Polymorphisms in the IL1-b gene are associated with increased Glu and Glx levels in treatment-resistant depression.

  2021cites this paper
• The Functional and Structural Consequences of Aberrant Microglial Activity in Major Depressive Disorder

  2021cites this paper
• Does cognitive behaviour therapy affect peripheral inflammation of depression? A protocol for the systematic review and meta-analysis

  2021cites this paper
• Integrating the monoamine and cytokine hypotheses of depression: Is histamine the missing link?

  2021cites this paper
• The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson’s Disorder and Therapeutic Implications

  2021cites this paper
• The effects of genotype on inflammatory response in hippocampal progenitor cells: A computational approach

  2021cites this paper
• Association between serum lipid concentrations and attempted suicide in patients with major depressive disorder: A meta-analysis

  2020cites this paper
• The rat hippocampal gliovascular system following one week vortioxetine and fluoxetine.

  2020cites this paper
• Possible Involvement of the IL-6/JAK2/STAT3 Pathway in the Hypothalamus in Depressive-Like Behavior of Rats Exposed to Chronic Mild Stress

  2020cites this paper
• Glycemic Variability and CNS Inflammation: Reviewing the Connection

  2020cites this paper
• Multinutrients for the Treatment of Psychiatric Symptoms in Clinical Samples: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2020cites this paper
• Curcumin in antidepressant treatments: An overview of potential mechanisms, pre‐clinical/clinical trials and ongoing challenges

  2020cites this paper
• Current views of diabetic peripheral neuropathic pain comorbid depression - a review.

  2020cites this paper
• Reconsidering the reasons for heightened inflammation in major depressive disorder.

  2020cites this paper
• The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder

  2020cites this paper
• Stress‐related suppression of peripheral cytokines predicts future relapse in alcohol‐dependent individuals with and without subclinical depression

  2019cites this paper
• Diversiform Etiologies for Post-stroke Depression

  2019cites this paper
• Sufentanil Preconditioning Protects Against Hepatic Ischemia-Reperfusion Injury by Suppressing Inflammation

  2019cites this paper
• Altered temporal sensitivity in obesity is linked to pro-inflammatory state

  2019cites this paper
• Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder

  2019cites this paper
• The Unique Nature of Depression and Anxiety among College Students with Adverse Childhood Experiences

  2019cites this paper
• Astrocyte, a Promising Target for Mood Disorder Interventions

  2019cites this paper
• An investigation on anti-depressant activity of fresh fruit juice of Malus domestica in experimental animal models

  2019cites this paper
• Astrocyte-Conditioned Medium Protects Prefrontal Cortical Neurons from Glutamate-Induced Cell Death by Inhibiting TNF-α Expression

  2019cites this paper
• Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review

  2019cites this paper
• Cross-sectional study of neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in mood disorders.

  2019cites this paper
• Blood Cell Counts and Blood Cell Ratios as Non-Specific Major Depressive Disorder Biomarkers

  2019cites this paper
• Can we predict treatment response in children with ADHD to a vitamin‐mineral supplement? An investigation into pre‐treatment nutrient serum levels, MTHFR status, clinical correlates and demographic variables

  2019cites this paper
• Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis.

  2019cites this paper
• NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms.

  2019cites this paper
• Functional Change of Brain Serotonergic Activity and Free Tryptophan in the Plasma of Depressed Women

  2019cites this paper
• Effects of Bacterial Endotoxin (LPS) on Cardiac and Synaptic Function in Various Animal Models: Larval Drosophila, Crayfish, Crab and Rodent

  2019cites this paper
• Translational Medicine Strategies in Drug Development for Mood Disorders

  2019cites this paper
• Dietary and Micronutrient Treatments for Children with Neurodevelopment Disorders

  2018cites this paper
• From feedback loop transitions to biomarkers in the psycho‐immune‐neuroendocrine network: Detecting the critical transition from health to major depression

  2018cites this paper
• Effect of Psoriasis on Quality of life

  2018cites this paper
• Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta‐analysis

  2018cites this paper
• The role of neuroinflammation and neurovascular dysfunction in major depressive disorder

  2018cites this paper
• The Association of Dry Eye Symptom Severity and Comorbid Insomnia in US Veterans

  2018cites this paper
• Non-alcoholic beverage consumption and risk of depression: epidemiological evidence from observational studies

  2018cites this paper
• Green Tea, Coffee, and Caffeine Consumption Are Inversely Associated with Self-Report Lifetime Depression in the Korean Population

  2018cites this paper
• Protective role of fentanyl in lipopolysaccharide-induced neuroinflammation in BV-2 cells.

  2018cites this paper
• Association between single nucleotide polymorphisms of TPH1 and TPH2 genes, and depressive disorders

  2018cites this paper
• Immune and Neuroprotective Effects of Physical Activity on the Brain in Depression

  2018cites this paper
• Early Maternal Deprivation Induces Microglial Activation, Alters Glial Fibrillary Acidic Protein Immunoreactivity and Indoleamine 2,3-Dioxygenase during the Development of Offspring Rats

  2018cites this paper
• An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases

  2018cites this paper
• Targeting the NMDA receptor/NO signalling pathway following L-α aminoadipic acid-induced astrocytic impairment and associated changes in the structural plasticity of neurons

  2018cites this paper
• The Association Between University Sport Participation and Well-Being of Former Athletes in Mid-Adulthood: A Focus on Prior Concussions and Type of Sport Played

  2018cites this paper
• Moderation of the relationship between Toxoplasma gondii seropositivity and trait impulsivity in younger men by the phenylalanine-tyrosine ratio.

  2018cites this paper
• A Review of Neutrophil-Lymphocyte, MonocyteLymphocyte, and Platelet-Lymphocyte Ratios Use in Psychiatric Disorders

  2018cites this paper
• Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice

  2018cites this paper
• Activation of the peripheral immune system regulates neuronal aromatase in the adult zebra finch brain

  2017cites this paper
• Peripheral immune system suppression in early abstinent alcohol-dependent individuals: Links to stress and cue-related craving

  2017cites this paper
• Antidepressant like effects of hydrolysable tannins of Terminalia catappa leaf extract via modulation of hippocampal plasticity and regulation of monoamine neurotransmitters subjected to chronic mild stress (CMS).

  2017cites this paper
• Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease

  2017cites this paper
• Immunometabolic dysregulation is associated with reduced cortical thickness of the anterior cingulate cortex.

  2017cites this paper
• The molecular aspects of oxidative & nitrosative stress and the tryptophan catabolites pathway (TRYCATs) as potential causes of depression.

  2017cites this paper
• Thalamocortical connectivity in major depressive disorder.

  2017cites this paper
• TFOS DEWS II pain and sensation report.

  2017cites this paper